 |
AvenCell Therapeutics
CEO - Andrew Schiermeier
USA | Funding: $112M (+)
Website: https://www.avencell.com/
AvenCell Therapeutics develops next generation immunotherapies for hard-to-treat cancers.
Website: https://www.avencell.com/
AvenCell Therapeutics develops next generation immunotherapies for hard-to-treat cancers.
